title: Outcomes from intensive training in genetic cancer risk counseling for clinicians.
abstract: OBJECTIVE
  Genetic cancer risk assessment is an emerging interdisciplinary practice that requires knowledge of genetics and oncology and specialized patient and family counseling skills. There is a growing need for cancer risk assessment practitioners, but most clinicians have inadequate cross-disciplinary training. An interdisciplinary course was developed to promote practitioner-level competency in cancer risk assessment to community-based clinicians. METHODS Participants were competitively selected from a pool of board-certified/eligible genetic counseling, masters-trained advanced practice nursing and physician applicants. Preference was given to clinicians with strong institutional backing practicing in underserved regions. The Continuing Medical Education/Continuing Education Unit-accredited course included didactic lectures, workshops, counseling practicum, and case conferences. Pre- and postcourse knowledge tests measured cancer genetics knowledge. Six month and one-year postcourse practice outcome surveys measured the impact of the program on professional self-efficacy and continued professional development.
  
  
  CONCLUSIONS
  Forty clinicians completed the course (23 genetic counselors, 14 nurses, and three physicians). There was a significant overall increase of 22.6% in postcourse knowledge scores (P < 0.001). Thirty-five (88%) completed prescribed practice development activities. Of 29 respondents to 1-year postcourse survey, 76% reported increased professional self-efficacy; 66% reported increase in number of patients seen, and virtually all indicated interest in additional training. Outcomes demonstrate the value and efficacy of interdisciplinary training in genetic cancer risk assessment targeted to motivated community-based clinicians. Courses such as this can help address the need for competent cancer risk assessment services in communities outside the academic health center.
authors.affiliation: Department of Clinical Cancer Genetics, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California, USA.
authors.forename: Kathleen R
authors.initials: KR
authors.lastname: Blazer
authors.forename: Deborah J
authors.initials: DJ
authors.lastname: MacDonald
authors.forename: Charite
authors.initials: C
authors.lastname: Ricker
authors.forename: Sharon
authors.initials: S
authors.lastname: Sand
authors.forename: Gwen C
authors.initials: GC
authors.lastname: Uman
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Weitzel
mesh_terms: D004502:Education, Medical, Continuing / Q000379:methods / Q000639:trends; D005817:Genetic Counseling / Q000379:methods / Q000639:trends; D005820:Genetic Testing / Q000379:methods; D019538:Health Care Surveys; D006801:Humans; D009369:Neoplasms / Q000235:genetics*; D018570:Risk Assessment / Q000379:methods / Q000639:trends; D012307:Risk Factors